You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Glenmark Generics Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for GLENMARK GENERICS, and what generic and branded alternatives to GLENMARK GENERICS drugs are available?

GLENMARK GENERICS has sixty-seven approved drugs.

There are three tentative approvals on GLENMARK GENERICS drugs.

Summary for Glenmark Generics
US Patents:0
Tradenames:58
Ingredients:53
NDAs:67

Drugs and US Patents for Glenmark Generics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics FLUCONAZOLE fluconazole TABLET;ORAL 077253-002 Jan 25, 2006 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Glenmark Generics PRAMIPEXOLE DIHYDROCHLORIDE pramipexole dihydrochloride TABLET;ORAL 090781-006 Sep 11, 2015 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Glenmark Generics TOPIRAMATE topiramate TABLET;ORAL 077627-002 Mar 27, 2009 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for GLENMARK GENERICS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.